了解Pseudomonas aeruginosa获得的耐药性以及可能的药理方法来缓解其病变发生
Mony Thakur1, Khushboo2, Yatin Kumar1
1Department of Microbiology, Central University of Haryana, Mahendergarh, Haryana 123031, India.
Biochemical pharmacology
|July 22, 2023
概括
由于抗生素耐药性和生物膜形成,Pseudomonas aeruginosa感染很难治疗. 用天然化合物准定数感应 (QS) 和生物膜提供了一个有前途的抗病毒策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 细菌病原体的产生
背景情况:
- Pseudomonas aeruginosa 是一种病房病原体,可引起严重感染,特别是在免疫功能低下的人群中.
- 它采用各种毒性因素,包括皮奥,蛋白酶和外毒素,有助于宿主入侵和持久性.
- 抗生素耐药性和P. aeruginosa的生物膜形成在临床环境中构成重大挑战,导致慢性感染和死亡率增加.
研究的目的:
- 审查P. aeruginosa.抗生素耐药性的机制.
- 探索替代性抗病毒策略,重点关注抗生物膜和抗定数感应 (QS) 方法.
- 突出植物化学品和精油在打击P. aeruginosa病原性方面的潜力.
主要方法:
- 对P. aeruginosa毒性因子,抗生素耐药性和生物膜形成研究的文献综述.
- 对定数感应 (QS) 机制的分析,特别是 LasR 调节蛋白的作用.
- 对抗生物膜和抗QS活性的药理方法的评估,包括天然化合物.
主要成果:
- P. aeruginosa利用多种毒性因素,并表现出对常规抗生素的耐药性.
- 生物膜形成是慢性感染和治疗失败的关键因素.
- 通过植物化学品和精油等自然产品抑制QS和生物膜的形成,在实验室环境中显示出有希望的结果.
结论:
- 制定破坏P. aeruginosa生物膜和克服抗生素耐药性的策略至关重要.
- 针对QS和生物膜形成的抗病毒方法代表了传统抗生素的可行替代方案.
- 用对抗分子准LasR蛋白是P. aeruginosa感染的潜在治疗途径.
更多相关视频
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.1K
11:35Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
8.2K
相关概念视频
01:28Gene Regulation in Microbial Communities: Quorum Sensing
40
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
40
01:30Development of Antibiotic Resistance
42
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
42
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359